Treatment of Endometrial Cancer.

Chung, Hyun Hoon; Song, Yong Sang

Review

Korean Journal of Obstetrics & Gynecology 2006;49(11):2253-2265.
Published online November 1, 2006.

Treatment of Endometrial Cancer.

Hyun Hoon Chung, Yong Sang Song

Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea. yssong@snu.ac.kr

Abstract

Endometrial cancer develops in about 142,000 women worldwide, and an estimated 42,000 women die from this cancer. The typical age-incidence curve for endometrial cancer shows that most cases are diagnosed after the menopause. The appearance of symptoms early in the course explains why most women with endometrial cancer have early-stage disease at presentation. For all stages taken together, the overall 5-year survival is around 80%. There is a substantial prognostic difference between the histological types of endometrial cancers. The most common lesions (type I) are typically hormone sensitive and low stage and have an excellent prognosis, whereas tumors of type II are high grade with a tendency to recur, even in early stage. The cornerstone of treatment for endometrial cancer is surgery, which not only is important for staging purposes but also enables appropriate tailoring of adjuvant treatment modalities that benefit high-risk patients only. We review current concepts about treatment of endometrial cancer.

Key Words: Endometrial cancer, Treatment